Detalles de la búsqueda
1.
Whole-genome sequencing facilitates patient-specific quantitative PCR-based minimal residual disease monitoring in acute lymphoblastic leukaemia, neuroblastoma and Ewing sarcoma.
Br J Cancer
; 126(3): 482-491, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34471258
2.
Measurable residual disease analysis in paediatric acute lymphoblastic leukaemia patients with ABL-class fusions.
Br J Cancer
; 127(5): 908-915, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35650277
3.
Methotrexate-related central neurotoxicity: clinical characteristics, risk factors and genome-wide association study in children treated for acute lymphoblastic leukemia.
Haematologica
; 107(3): 635-643, 2022 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33567813
4.
Prospective longitudinal evaluation of treatment-related toxicity and health-related quality of life during the first year of treatment for pediatric acute lymphoblastic leukemia.
BMC Cancer
; 22(1): 985, 2022 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36109702
5.
Mouse models of high-risk neuroblastoma.
Cancer Metastasis Rev
; 39(1): 261-274, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31989509
6.
Determinants of social functioning among adolescents and young adults with cancer: A systematic review.
Psychooncology
; 30(10): 1626-1642, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34081823
7.
Outcomes for Australian children with relapsed/refractory acute lymphoblastic leukaemia treated with blinatumomab.
Pediatr Blood Cancer
; 68(5): e28922, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33638292
8.
The Australia and New Zealand Cardio-Oncology Registry: evaluation of chemotherapy-related cardiotoxicity in a national cohort of paediatric cancer patients.
Intern Med J
; 51(2): 229-234, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31841257
9.
CD30 and ALK combination therapy has high therapeutic potency in RANBP2-ALK-rearranged epithelioid inflammatory myofibroblastic sarcoma.
Br J Cancer
; 123(7): 1101-1113, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32684628
10.
Accelerating development of high-risk neuroblastoma patient-derived xenograft models for preclinical testing and personalised therapy.
Br J Cancer
; 122(5): 680-691, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31919402
11.
Optimization of a clofarabine-based drug combination regimen for the preclinical evaluation of pediatric acute lymphoblastic leukemia.
Pediatr Blood Cancer
; 67(4): e28133, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31876116
12.
Enrolment in paediatric oncology early-phase clinical trials: The health-care professionals' perspective.
J Paediatr Child Health
; 55(5): 561-566, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30288839
13.
Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial.
Lancet Oncol
; 19(12): 1617-1629, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30442501
14.
A risk score including microdeletions improves relapse prediction for standard and medium risk precursor B-cell acute lymphoblastic leukaemia in children.
Br J Haematol
; 180(4): 550-562, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29194562
15.
Increased Survival for Children With Acute Myeloid Leukemia Results From Improved Postrelapse Treatment.
J Pediatr Hematol Oncol
; 40(7): 541-547, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29794644
16.
Alectinib is effective, safe and tolerable in an adolescent with stage IVB ALK-rearranged adenocarcinoma of the lung.
Pediatr Hematol Oncol
; 35(7-8): 415-421, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30526220
17.
Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial.
Lancet Oncol
; 18(4): 500-514, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28259608
18.
Haematopoietic stem cell transplantation for primary immunodeficiency syndromes: A 5-year single-centre experience.
J Paediatr Child Health
; 53(10): 988-994, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-28752571
19.
Persistent MRD before and after allogeneic BMT predicts relapse in children with acute lymphoblastic leukaemia.
Br J Haematol
; 168(3): 395-404, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25312094
20.
Bronchial carcinoid tumour identified as the cause for recurrent pneumonia in a 10-year-old boy.
J Paediatr Child Health
; 56(4): 642-644, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-31517413